Cyclosporin A inhibits vaccinia virus replication in vitro.
The effect of the immune modulator, Cyclosporin A (CsA) on vaccinia virus replication has been examined in cell cultures. In the present study we report that CsA is anti-viral towards vaccinia virus. Viral yield was inhibited by more than 97% after 24 h postinfection in the presence of 16 microM to 40 microM CsA. An analysis of the infectious cycle in greater detail revealed that CsA did not effect the total level of [35S] methionine incorporation into vaccinia infected cells. However, both early and late viral gene expression were inhibited by CsA. Late viral protein synthesis appeared to be more sensitive to the drug. At least one late viral polypeptide of approximately Mr 38,000 was virtually undetected up to 8 h postinfection in the presence of 40 microM CsA. Host protein synthesis which is normally inhibited by the virus was not turned off until very late in infection. Viral DNA replication was also inhibited by the addition of CsA at levels comparable to those observed for late protein synthesis.
Damaso
C R
CR
Department of Biological Sciences, University of Cincinnati, Ohio.
Keller
S J
SJ
D000818:Animals; D000998:Antiviral Agents / Q000494:pharmacology* / Q000633:toxicity; D002460:Cell Line; D016572:Cyclosporine / Q000494:pharmacology* / Q000633:toxicity; D004279:DNA, Viral / Q000096:biosynthesis / Q000187:drug effects; D000882:Haplorhini; D011994:Recombinant Proteins / Q000096:biosynthesis; D014616:Vaccinia virus / Q000187:drug effects* / Q000502:physiology; D014764:Viral Proteins / Q000187:drug effects; D014779:Virus Replication / Q000187:drug effects; D001616:beta-Galactosidase / Q000096:biosynthesis
D000998:Antiviral Agents; D004279:DNA, Viral; D011994:Recombinant Proteins; D014764:Viral Proteins; D016572:Cyclosporine; D001616:beta-Galactosidase